PMID- 19170842 OWN - NLM STAT- MEDLINE DCOM- 20090713 LR - 20211020 IS - 1743-6109 (Electronic) IS - 1743-6095 (Print) IS - 1743-6095 (Linking) VI - 6 IP - 1 DP - 2009 Jan TI - TNF-alpha knockout mice have increased corpora cavernosa relaxation. PG - 115-25 LID - 10.1111/j.1743-6109.2008.01029.x [doi] AB - INTRODUCTION: Erectile dysfunction is considered an early clinical manifestation of vascular disease and an independent risk factor for cardiovascular events associated with endothelial dysfunction and increased levels of pro-inflammatory cytokines. Tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine, suppresses endothelial nitric oxide synthase (eNOS) expression. AIM: Considering that nitric oxide (NO) is of critical importance in penile erection, we hypothesized that blockade of TNF-alpha actions would increase cavernosal smooth muscle relaxation. METHODS: In vitro organ bath studies were used to measure cavernosal reactivity in wild type and TNF-alpha knockout (TNF-alpha KO) mice and NOS expression was evaluated by western blot. In addition, spontaneous erections (in vivo) were evaluated by videomonitoring the animals (30 minutes). Collagen and elastin expression were evaluated by Masson trichrome and Verhoff-van Gieson stain reaction, respectively. MAIN OUTCOME MEASURES: Corpora cavernosa from TNF-alpha KO mice exhibited increased NO-dependent relaxation, which was associated with increased eNOS and neuronal NOS (nNOS) cavernosal expression. RESULTS: Cavernosal strips from TNF-alpha KO mice displayed increased endothelium-dependent (97.4 +/- 5.3 vs. CONTROL: 76.3 +/- 6.3, %) and nonadrenergic-noncholinergic (93.3 +/- 3.0 vs. CONTROL: 67.5 +/- 16.0; 16 Hz) relaxation compared to control animals. These responses were associated with increased protein expression of eNOS and nNOS (P < 0.05). Sympathetic-mediated (0.69 +/- 0.16 vs. CONTROL: 1.22 +/- 0.22; 16 Hz) as well as phenylephrine-induced contractile responses (1.6 +/- 0.1 vs. CONTROL: 2.5 +/- 0.1, mN) were attenuated in cavernosal strips from TNF-alpha KO mice. Additionally, corpora cavernosa from TNF-alpha KO mice displayed increased collagen and elastin expression. In vivo experiments demonstrated that TNF-alpha KO mice display increased number of spontaneous erections. CONCLUSION: Corpora cavernosa from TNF-alpha KO mice display alterations that favor penile tumescence, indicating that TNF-alpha plays a detrimental role in erectile function. A key role for TNF-alpha in mediating endothelial dysfunction in ED is markedly relevant since we now have access to anti-TNF-alpha therapies. FAU - Carneiro, Fernando S AU - Carneiro FS AD - Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo; Sao Paulo, SP, Brazil. fcarneiro@mcg.edu FAU - Sturgis, Lashon C AU - Sturgis LC FAU - Giachini, Fernanda R C AU - Giachini FR FAU - Carneiro, Zidonia N AU - Carneiro ZN FAU - Lima, Victor V AU - Lima VV FAU - Wynne, Brandi M AU - Wynne BM FAU - San Martin, Sebastian AU - San Martin S FAU - Brands, Michael W AU - Brands MW FAU - Tostes, Rita C AU - Tostes RC FAU - Webb, R Clinton AU - Webb RC LA - eng GR - R01 HL071138/HL/NHLBI NIH HHS/United States GR - R01 HL071138-06/HL/NHLBI NIH HHS/United States GR - HL71138/HL/NHLBI NIH HHS/United States GR - HL74167/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - J Sex Med JT - The journal of sexual medicine JID - 101230693 RN - 0 (Tumor Necrosis Factor-alpha) RN - 9007-34-5 (Collagen) RN - 9007-58-3 (Elastin) RN - EC 1.14.13.39 (Nitric Oxide Synthase) SB - IM MH - Animals MH - Collagen/metabolism MH - Elastin/metabolism MH - Endothelium, Vascular/immunology/metabolism/pathology MH - Erectile Dysfunction/*immunology/metabolism/*therapy MH - Male MH - Mice MH - Mice, Knockout MH - Muscle, Smooth/*immunology/metabolism/pathology MH - Nitric Oxide Synthase/metabolism MH - Penis MH - Tumor Necrosis Factor-alpha/*immunology MH - Vasodilation/*physiology PMC - PMC2843140 MID - NIHMS170297 EDAT- 2009/01/28 09:00 MHDA- 2009/07/14 09:00 PMCR- 2010/03/22 CRDT- 2009/01/28 09:00 PHST- 2009/01/28 09:00 [entrez] PHST- 2009/01/28 09:00 [pubmed] PHST- 2009/07/14 09:00 [medline] PHST- 2010/03/22 00:00 [pmc-release] AID - S1743-6095(15)32253-0 [pii] AID - 10.1111/j.1743-6109.2008.01029.x [doi] PST - ppublish SO - J Sex Med. 2009 Jan;6(1):115-25. doi: 10.1111/j.1743-6109.2008.01029.x.